Veterinary Renal Disease Global Market Report 2025
상품코드:1793445
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
동물 신장질환 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 213억 1,000만 달러로 성장하며 CAGR은 6.5%에 이릅니다. 예측기간의 성장은 개별화 수의료의 출현, 수의의료에서의 원격의료와 원격 모니터링의 확대, 수의의 임상시험과 연구 증가, 수의의 제품공급체인 투명화를 위한 블록체인 기술의 채용, 수의의 진단에 있어서의 인공지능과 머신러닝의 통합에 기인한다고 생각됩니다. 예측 기간의 주요 동향은 수의사 원격 상담 수요 증가, 맞춤형 반려동물 영양 계획 급증, 반려동물용 웨어러블 건강 모니터링 장치의 성장, 수의사 원격 의료 플랫폼 확대, 수의사 종양학에서 정밀의료 채택 등을 포함합니다.
향후 5년간의 성장률 6.5%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 투석액 및 신장 전용식이요법에 대한 수입세는 반려동물의 만성 신장병 관리 비용을 증가시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.
반려동물 사육 증가는 동물 신장질환 시장 성장을 가속할 것으로 예측됩니다. 이 시장은 동물의 신장에 영향을 미치며 신장 기능의 저하, 인후 갈증, 빈뇨, 체중 감소 등의 증상을 일으키는 상태에 중점을 둡니다. 동물 신장질환 증가는 반려동물의 수명 연장, 환경 독소 노출, 식이 요인, 유전 적 소인에 기인합니다. 동물 신장질환의 치료에는 일반적으로 식이 관리, 약물 요법, 주입 요법이 수행되어 증상을 관리하고 삶의 질을 향상시킵니다. 예를 들어, Cooper Pet Care사의 보고에 의하면, 노르웨이와 스위스를 포함한 유럽 연합(EU)의 반려동물 사육수는 2021년의 약 1억 4,000만마리로부터 2022년 10월에는 약 1억 4,500만마리로 증가해, 개 약 6,600만마리, 고양이 약 7,900만 마리에 달했습니다. 따라서 반려동물 사육 증가는 동물 신장질환 시장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 동물 신장질환 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 동물 신장질환 시장 : 성장률 분석
세계의 동물 신장질환 시장 실적 : 규모와 성장(2019-2024년)
세계의 동물 신장질환 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 동물 신장질환 : 전체 시장(TAM)
제6장 시장 세분화
세계의 동물 신장질환 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진단
치료
세계의 동물 신장질환 시장 : 동물 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개
고양이
소
말
기타 동물 유형
세계의 동물 신장질환 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
신부전
만성 신장 질환(CKD)
신성 방광염
신장 결석
신염
기타 적응증
세계의 동물 신장질환 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
주사제
경구
세계의 동물 신장질환 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약국
반려동물 전문점
전자상거래
기타 유통 채널
세계의 동물 신장질환 시장 : 진단 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈액검사
소변 검사
이미징
생검
세계의 동물 신장질환 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의약품
투석
신장 이식
수액 요법
제7장 지역별/국가별 분석
세계의 동물 신장질환 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 동물 신장질환 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
동물 신장질환 시장 : 경쟁 구도
동물 신장질환 시장 : 기업 프로파일
Bayer HealthCare Animal Health Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Nestle Purina PetCare Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Zoetis Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Boehringer Ingelheim : 개요, 제품 및 서비스, 전략 및 재무 분석
Covetrus Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Elanco Animal Health Incorporated
Hill's Pet Nutrition Inc.
IDEXX Laboratories Inc.
Ceva Sante Animale SA
Dechra Pharmaceuticals PLC
Neogen Corporation
Vetoquinol SA
Norbrook Laboratories Limited
Nutramax Laboratories Veterinary Sciences Inc.
Animalcare Group plc
Antech Diagnostics Inc.
Kindred Biosciences Inc.
Vedco Inc.
MSD Animal Health
Clinical Renal Associates
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
동물 신장질환 시장(2029년) : 새로운 기회를 제공하는 국가
동물 신장질환 시장(2029년) : 새로운 기회를 제공하는 부문
동물 신장질환 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Veterinary renal disease encompasses a range of conditions that affect the kidneys of animals, resulting in impaired kidney function. This disruption affects the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues.
The main types of veterinary renal disease involve diagnosis and treatment. Diagnosis involves reaching a conclusion through medical evaluation, identifying specific conditions or diseases affecting an individual animal's health. The types of animals affected include canine, feline, bovine, equine, and others, with indications such as renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, among others. Treatment can be administered via injectable or oral routes and products are distributed through pharmacies, pet specialty stores, e-commerce platforms, and other channels.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.
The veterinary renal disease market research report is one of a series of new reports from The Business Research Company that provides veterinary renal disease market statistics, including veterinary renal disease industry global market size, regional shares, competitors with a veterinary renal disease market share, detailed veterinary renal disease market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary renal disease industry. This veterinary renal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary renal disease market size has grown strongly in recent years. It will grow from $15.5 billion in 2024 to $16.59 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growing disease awareness initiatives, the shift in consumer preferences towards natural and organic pet food, increasing pet ownership rates globally, regulatory changes in veterinary pharmaceuticals, and growing awareness about pet health and nutrition.
The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the emergence of personalized veterinary medicine, expansion of telemedicine and remote monitoring in veterinary care, rise in veterinary clinical trials and research, adoption of blockchain technology for supply chain transparency in veterinary products, and integration of artificial intelligence and machine learning in veterinary diagnostics. Major trends in the forecast period include increasing demand for veterinary teleconsultations, the surge in customized pet nutrition plans, the growth of wearable health monitoring devices for pets, the expansion of veterinary telemedicine platforms, and the adoption of precision medicine in veterinary oncology.
The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Import taxes on dialysis solutions and renal-specific diets may increase the cost of managing chronic kidney diseases in companion animals. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Increased pet ownership is expected to drive growth in the veterinary renal disease market. This market focuses on conditions affecting animals' kidneys, leading to impaired kidney function and symptoms such as increased thirst, frequent urination, and weight loss. The rise in veterinary renal disease is attributed to longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Treatments for veterinary renal disease typically involve dietary management, medication, and fluid therapy to manage symptoms and improve quality of life. For example, Cooper Pet Care reported that the European Union, including Norway and Switzerland, is expected to have around 145 million pets by October 2022, up from approximately 140 million in 2021, with about 66 million dogs and 79 million cats. Therefore, the growth of pet ownership is fueling the veterinary renal disease market.
Key players in this market are focused on advancing treatment and diagnosis technologies, such as novel diagnostic tests capable of detecting kidney injury even before clinical signs appear. These tests aim to identify subtle changes in renal function or structure, enabling early intervention to prevent advanced renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc. introduced the IDEXX Cystatin B Test, the first veterinary diagnostic test for detecting kidney injury in cats and dogs. This test helps veterinarians identify kidney injury early, leading to improved patient outcomes. It will be integrated into test panels assessing renal health during an estimated two million patient visits annually.
In July 2022, Dechra Pharmaceuticals plc acquired Piedmont Animal Health LLC for $210 million, enhancing its product development capabilities and offering innovative solutions for veterinarians and pet owners in areas of unmet medical needs, including veterinary renal disease. Piedmont Animal Health LLC is known for providing medicines for this specific condition.
North America was the largest region in the veterinary renal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the veterinary renal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Renal Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on veterinary renal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary renal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary renal disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Diagnosis; Treatment
2) By Animal Type: Canine; Feline; Bovine; Equine; Other Animal Types
3) By Indication: Renal Failure; Chronic Kidney Disease (CKD); Renal Cystitis; Kidney Stones; Nephritis; Other Indications
4) By Route of Administration: Injectable; Oral
5) By Distribution Channel: Pharmacies; Pet Specialty Stores; E-commerce; Other Distribution Channels
Subsegments:
1) By Diagnosis: Blood Tests; Urine Tests; Imaging; Biopsy
2) By Treatment: Medications; Dialysis; Kidney Transplantation; Fluid Therapy
3. Veterinary Renal Disease Market Trends And Strategies
4. Veterinary Renal Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Veterinary Renal Disease Growth Analysis And Strategic Analysis Framework
5.1. Global Veterinary Renal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Renal Disease Market Growth Rate Analysis
5.4. Global Veterinary Renal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Renal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Renal Disease Total Addressable Market (TAM)
6. Veterinary Renal Disease Market Segmentation
6.1. Global Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnosis
Treatment
6.2. Global Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine
Feline
Bovine
Equine
Other Animal Types
6.3. Global Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Renal Failure
Chronic Kidney Disease (CKD)
Renal Cystitis
Kidney Stones
Nephritis
Other Indications
6.4. Global Veterinary Renal Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
6.5. Global Veterinary Renal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacies
Pet Speciality Stores
E-commerce
Other Distribution Channels
6.6. Global Veterinary Renal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Tests
Urine Tests
Imaging
Biopsy
6.7. Global Veterinary Renal Disease Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Dialysis
Kidney Transplantation
Fluid Therapy
7. Veterinary Renal Disease Market Regional And Country Analysis
7.1. Global Veterinary Renal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Renal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
